GlassScriptPhysician profile
Mark A Haber
NPI 1710089404
$5,534.22
in general payments reported to CMS, 2019-2025
46 companies · $443 in 2025
The $443 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,682 · 2020: $499 · 2021: $756 · 2022: $1,032 · 2023: $482 · 2024: $640 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,138.38 | 2019-2024 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $434.96 | 2020-2025 | Lumenis Pulse 100h, Tria Firm |
| Dendreon Pharmaceuticals LLC | $391.44 | 2019-2024 | Provenge |
| Pfizer INC. | $371.21 | 2019-2025 | |
| Blue Earth Diagnostics | $334.08 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $281.79 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Endo Pharmaceuticals INC. | $240.74 | 2020-2023 | Aveed, Xiaflex |
| Astrazeneca Pharmaceuticals LP | $219.91 | 2021-2025 | Lynparza |
| Neotract INC. | $216.12 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $209.92 | 2019-2025 | |
| Myovant Sciences INC. | $177.00 | 2021-2022 | |
| Srs Medical Systems, INC. | $120.02 | 2019 | |
| Coloplast Corp | $118.48 | 2020-2025 | Speedicath |
| Medtronic, INC. | $99.21 | 2021-2025 | Interstim |
| Amgen INC. | $98.62 | 2019-2023 | Prolia |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Haber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.